CEO of Hemispherx BioPharma just picked up 68,493 shares

Thomas K. Equels, CEO of Hemispherx BioPharma and a director of the company, recently acquired 68,493 shares of the company. The buys took place at $0.73 per share, on December 22, 2016. Equels now owns 220,455 shares of the company. Equels operates out of Coral Gables, FL.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Hemispherx BioPharma makes a similar move, sign up!

Other recent filings from the company include the following:

Hemispherx BioPharma's CEO & President just picked up 12,316 shares - Sept. 3, 2020
Regulation FD - Aug. 31, 2020
Regulation FD - Aug. 31, 2020

Auto Refresh